Prophylaxis With Topical Azithromycin Against Lyme borreliosis

Authors

E Shapiro
Gary Wormser, New York Medical CollegeFollow

DOI

10.1016/S1473-3099(16)30551-5

Journal Title

The Lancet.Infectious Diseases

First Page

246

Last Page

248

Document Type

Response or Comment

Publication Date

3-1-2017

Department

Medicine

Keywords

Azithromycin, Borrelia burgdorferi group, Lyme disease, humans

Disciplines

Bacterial Infections and Mycoses | Medicine and Health Sciences

Comments

Refers to Schwameis et al.'s article Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial

https://doi.org/10.1016/S1473-3099(16)30529-1

Recommended Citation

Shapiro, E., & Wormser, G. (2017). Prophylaxis With Topical Azithromycin Against Lyme borreliosis. The Lancet.Infectious Diseases, 17 (3), 246-248. https://doi.org/10.1016/S1473-3099(16)30551-5